Dr Agarwal’s Health Care Raises Rs 650 Cr From TPG, Temasek

Eye Hospitals chain Dr Agarwal’s Health Care (DAHCL) has raised Rs 650 crore from existing investors TPG Growth (the middle market and growth equity platform of leading global alternative asset management firm, TPG) and Temasek, (a global investment company headquartered in Singapore).  

The fundraiser will provide significant capital to fuel the company’s expansion plans.

The new fund will be used to deploy capital to expand the current network of 150+ centres to over 300+ centres in the next 3 years.

The company has new projects in development in Mumbai, Punjab, central and northern India, among others. The company continues to achieve growth and success in its key markets including Tamil Nadu, Karnataka, Maharashtra, Gujarat, Punjab, Telangana, Andhra Pradesh, Kerala, and West Bengal.

Along with the expansion of the network, the company will also be investing in technological advancements for vision correction such as SMILE, Laser Cataract Surgery and for advanced technologies to treat Vitreo-retinal diseases such as Diabetic Retinopathy and Age-related macular degeneration.

Prof. (Dr) Amar Agarwal, Chairman, Dr Agarwal’s Group of Eye Hospitals said, “Backing from investors such as TPG and Temasek, further affirms our faith in staying true to our vision of being a truly global healthcare organization which imbibes the best practices from different sectors while relying on continuous innovation and cutting-edge technology to serve our patients. The new investments will be used to expand our Indian and International footprint, along with acquiring the latest technologies for super-speciality eye care.”

Dr Adil Agarwal, CEO, Dr Agarwal’s Group of Eye Hospitals added, “The investment will be used to support the business through its next phase of growth, including the acquisition of small hospitals and chains as well as greenfield expansion of our network. We are looking at doubling our network in the next three years and are also looking to expand aggressively in Maharashtra, Punjab, Delhi, Uttar Pradesh, and central India besides penetrating deeper into our existing markets. We will also be establishing over 100 primary eye clinics in tier II and tier III towns in the next couple of years. Africa is another important geography for us. We have an existing network presence of 15 hospitals, and we will be deepening our presence in Kenya, Zambia, and Tanzania and look to add 10 centres across these countries.”

Veda Corporate Advisors was the financial advisor to Dr Agarwal’s Health Care on this transaction.